Endocardial Solutions Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 193

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $272M

Endocardial Solutions General Information

Description

Developer and manufacturer of diagnostic and therapeutic tools used to treat atrial fibrillation. The company develops products for diagnostic mapping of complex arrhythmias (abnormally rapid heartbeats caused by irregular electrical activity in the heart), the integrated system provides a 3D graphical display of the heart's electrical activity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1350 Energy Lane
  • Suite 100
  • Saint Paul, MN 55108
  • United States
+1 (651)
Primary Industry
Diagnostic Equipment
Acquirer
Corporate Office
  • 1350 Energy Lane
  • Suite 100
  • Saint Paul, MN 55108
  • United States
+1 (651)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocardial Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 13-Jan-2005 $272M Completed Generating Revenue
11. PIPE 20-Aug-2003 Completed Generating Revenue
10. PIPE 03-Jan-2003 Completed Generating Revenue
9. PIPE 26-Feb-2002 Completed Generating Revenue
8. PIPE 22-Mar-2001 Completed Generating Revenue
7. PIPE 29-Jun-2000 Completed Generating Revenue
6. PIPE 13-Jul-1999 Completed Generating Revenue
5. IPO 19-Mar-1997 Completed
4. Later Stage VC 01-Oct-1996 $80K $22.2M Completed Generating Revenue
3. Later Stage VC (Series C) 01-Apr-1996 $10M $22.1M Completed Generating Revenue
To view Endocardial Solutions’s complete valuation and funding history, request access »

Endocardial Solutions Patents

Endocardial Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003290900-A1 Congestive heart failure pacing optimization method and device Inactive 15-Nov-2002
WO-2004045468-A2 Congestive heart failure pacing optimization method and device Inactive 15-Nov-2002
WO-2004045468-A3 Congestive heart failure pacing optimization method and device Inactive 15-Nov-2002
US-6939309-B1 Electrophysiology mapping system Inactive 23-Sep-1993
US-6947785-B1 Interface system for endocardial mapping catheter Inactive 23-Sep-1993 A61B18/1492
To view Endocardial Solutions’s complete patent history, request access »

Endocardial Solutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endocardial Solutions Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affinity Capital Management Venture Capital Minority
Catalyst Ventures Venture Capital Minority
Chemicals & Materials Enterprise Associates Corporation Minority
Coral Group Venture Capital Minority
Marquette Venture Partners Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Endocardial Solutions FAQs

  • When was Endocardial Solutions founded?

    Endocardial Solutions was founded in 1992.

  • Where is Endocardial Solutions headquartered?

    Endocardial Solutions is headquartered in Saint Paul, MN.

  • What is the size of Endocardial Solutions?

    Endocardial Solutions has 193 total employees.

  • What industry is Endocardial Solutions in?

    Endocardial Solutions’s primary industry is Diagnostic Equipment.

  • Is Endocardial Solutions a private or public company?

    Endocardial Solutions is a Private company.

  • What is the current valuation of Endocardial Solutions?

    The current valuation of Endocardial Solutions is .

  • What is Endocardial Solutions’s current revenue?

    The current revenue for Endocardial Solutions is .

  • How much funding has Endocardial Solutions raised over time?

    Endocardial Solutions has raised $77.3M.

  • Who are Endocardial Solutions’s investors?

    Affinity Capital Management, Catalyst Ventures, Chemicals & Materials Enterprise Associates, Coral Group, and Marquette Venture Partners are 5 of 12 investors who have invested in Endocardial Solutions.

  • When was Endocardial Solutions acquired?

    Endocardial Solutions was acquired on 13-Jan-2005.

  • Who acquired Endocardial Solutions?

    Endocardial Solutions was acquired by St. Jude Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process